Global Xerophthalmia Treatment Market Size, Status and Forecast 2018-2025
- QYR2795428
- 106 Pages
- October 2018
- Medical Devices
This report focuses on the global Xerophthalmia Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Xerophthalmia Treatment development in United States, Europe and China.
The key players covered in this study
Allergan Plc
Novartis AG
Otsuka Pharmaceutical Co.,Ltd.
Abbott Laboratories
Santen Pharmaceutical Co Ltd
Valent Pharmaceuticals
Akorn, Inc
Shire Plc
Thea Pharmaceuticals Limited
OASIS Medical
Altaire Pharmaceuticals Inc
Boiron USA
Similasan Corporation
Scope Ophthalmics Ltd.
Reckitt Benckiser Group PLC
Medicom Healthcare Ltd
FDC Limited
Lupin Limited
Jamjoom Pharmaceuticals Co.
Sentiss Pharma Private limited
Market segment by Type, the product can be split into
Cyclosporin
Oral Corticosteroids
Artificial Tears
Punctal Plugs
Omega Supplements
Others
Market segment by Application, split into
Hospital Pharmacies
Eye Health Clinics
Retail Pharmacies
Online Pharmacies
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Xerophthalmia Treatment status, future forecast, growth opportunity, key market and key players.
To present the Xerophthalmia Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Xerophthalmia Treatment are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Xerophthalmia Treatment Market Size Growth Rate by Type (2013-2025)
1.4.2 Cyclosporin
1.4.3 Oral Corticosteroids
1.4.4 Artificial Tears
1.4.5 Punctal Plugs
1.4.6 Omega Supplements
1.4.7 Others
1.5 Market by Application
1.5.1 Global Xerophthalmia Treatment Market Share by Application (2013-2025)
1.5.2 Hospital Pharmacies
1.5.3 Eye Health Clinics
1.5.4 Retail Pharmacies
1.5.5 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Xerophthalmia Treatment Market Size
2.2 Xerophthalmia Treatment Growth Trends by Regions
2.2.1 Xerophthalmia Treatment Market Size by Regions (2013-2025)
2.2.2 Xerophthalmia Treatment Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Xerophthalmia Treatment Market Size by Manufacturers
3.1.1 Global Xerophthalmia Treatment Revenue by Manufacturers (2013-2018)
3.1.2 Global Xerophthalmia Treatment Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Xerophthalmia Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Xerophthalmia Treatment Key Players Head office and Area Served
3.3 Key Players Xerophthalmia Treatment Product/Solution/Service
3.4 Date of Enter into Xerophthalmia Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Xerophthalmia Treatment Market Size by Type (2013-2018)
4.2 Global Xerophthalmia Treatment Market Size by Application (2013-2018)
5 United States
5.1 United States Xerophthalmia Treatment Market Size (2013-2018)
5.2 Xerophthalmia Treatment Key Players in United States
5.3 United States Xerophthalmia Treatment Market Size by Type
5.4 United States Xerophthalmia Treatment Market Size by Application
6 Europe
6.1 Europe Xerophthalmia Treatment Market Size (2013-2018)
6.2 Xerophthalmia Treatment Key Players in Europe
6.3 Europe Xerophthalmia Treatment Market Size by Type
6.4 Europe Xerophthalmia Treatment Market Size by Application
7 China
7.1 China Xerophthalmia Treatment Market Size (2013-2018)
7.2 Xerophthalmia Treatment Key Players in China
7.3 China Xerophthalmia Treatment Market Size by Type
7.4 China Xerophthalmia Treatment Market Size by Application
8 Japan
8.1 Japan Xerophthalmia Treatment Market Size (2013-2018)
8.2 Xerophthalmia Treatment Key Players in Japan
8.3 Japan Xerophthalmia Treatment Market Size by Type
8.4 Japan Xerophthalmia Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Xerophthalmia Treatment Market Size (2013-2018)
9.2 Xerophthalmia Treatment Key Players in Southeast Asia
9.3 Southeast Asia Xerophthalmia Treatment Market Size by Type
9.4 Southeast Asia Xerophthalmia Treatment Market Size by Application
10 India
10.1 India Xerophthalmia Treatment Market Size (2013-2018)
10.2 Xerophthalmia Treatment Key Players in India
10.3 India Xerophthalmia Treatment Market Size by Type
10.4 India Xerophthalmia Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Xerophthalmia Treatment Market Size (2013-2018)
11.2 Xerophthalmia Treatment Key Players in Central & South America
11.3 Central & South America Xerophthalmia Treatment Market Size by Type
11.4 Central & South America Xerophthalmia Treatment Market Size by Application
12 International Players Profiles
12.1 Allergan Plc
12.1.1 Allergan Plc Company Details
12.1.2 Company Description and Business Overview
12.1.3 Xerophthalmia Treatment Introduction
12.1.4 Allergan Plc Revenue in Xerophthalmia Treatment Business (2013-2018)
12.1.5 Allergan Plc Recent Development
12.2 Novartis AG
12.2.1 Novartis AG Company Details
12.2.2 Company Description and Business Overview
12.2.3 Xerophthalmia Treatment Introduction
12.2.4 Novartis AG Revenue in Xerophthalmia Treatment Business (2013-2018)
12.2.5 Novartis AG Recent Development
12.3 Otsuka Pharmaceutical Co.,Ltd.
12.3.1 Otsuka Pharmaceutical Co.,Ltd. Company Details
12.3.2 Company Description and Business Overview
12.3.3 Xerophthalmia Treatment Introduction
12.3.4 Otsuka Pharmaceutical Co.,Ltd. Revenue in Xerophthalmia Treatment Business (2013-2018)
12.3.5 Otsuka Pharmaceutical Co.,Ltd. Recent Development
12.4 Abbott Laboratories
12.4.1 Abbott Laboratories Company Details
12.4.2 Company Description and Business Overview
12.4.3 Xerophthalmia Treatment Introduction
12.4.4 Abbott Laboratories Revenue in Xerophthalmia Treatment Business (2013-2018)
12.4.5 Abbott Laboratories Recent Development
12.5 Santen Pharmaceutical Co Ltd
12.5.1 Santen Pharmaceutical Co Ltd Company Details
12.5.2 Company Description and Business Overview
12.5.3 Xerophthalmia Treatment Introduction
12.5.4 Santen Pharmaceutical Co Ltd Revenue in Xerophthalmia Treatment Business (2013-2018)
12.5.5 Santen Pharmaceutical Co Ltd Recent Development
12.6 Valent Pharmaceuticals
12.6.1 Valent Pharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 Xerophthalmia Treatment Introduction
12.6.4 Valent Pharmaceuticals Revenue in Xerophthalmia Treatment Business (2013-2018)
12.6.5 Valent Pharmaceuticals Recent Development
12.7 Akorn, Inc
12.7.1 Akorn, Inc Company Details
12.7.2 Company Description and Business Overview
12.7.3 Xerophthalmia Treatment Introduction
12.7.4 Akorn, Inc Revenue in Xerophthalmia Treatment Business (2013-2018)
12.7.5 Akorn, Inc Recent Development
12.8 Shire Plc
12.8.1 Shire Plc Company Details
12.8.2 Company Description and Business Overview
12.8.3 Xerophthalmia Treatment Introduction
12.8.4 Shire Plc Revenue in Xerophthalmia Treatment Business (2013-2018)
12.8.5 Shire Plc Recent Development
12.9 Thea Pharmaceuticals Limited
12.9.1 Thea Pharmaceuticals Limited Company Details
12.9.2 Company Description and Business Overview
12.9.3 Xerophthalmia Treatment Introduction
12.9.4 Thea Pharmaceuticals Limited Revenue in Xerophthalmia Treatment Business (2013-2018)
12.9.5 Thea Pharmaceuticals Limited Recent Development
12.10 OASIS Medical
12.10.1 OASIS Medical Company Details
12.10.2 Company Description and Business Overview
12.10.3 Xerophthalmia Treatment Introduction
12.10.4 OASIS Medical Revenue in Xerophthalmia Treatment Business (2013-2018)
12.10.5 OASIS Medical Recent Development
12.11 Altaire Pharmaceuticals Inc
12.12 Boiron USA
12.13 Similasan Corporation
12.14 Scope Ophthalmics Ltd.
12.15 Reckitt Benckiser Group PLC
12.16 Medicom Healthcare Ltd
12.17 FDC Limited
12.18 Lupin Limited
12.19 Jamjoom Pharmaceuticals Co.
12.20 Sentiss Pharma Private limited
13 Market Forecast 2018-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2018-2025)
13.10 Market Size Forecast by Application (2018-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Xerophthalmia Treatment Key Market Segments
Table Key Players Xerophthalmia Treatment Covered
Table Global Xerophthalmia Treatment Market Size Growth Rate by Type 2013-2025 (Million US$)
Figure Global Xerophthalmia Treatment Market Size Market Share by Type 2013-2025
Figure Cyclosporin Figures
Table Key Players of Cyclosporin
Figure Oral Corticosteroids Figures
Table Key Players of Oral Corticosteroids
Figure Artificial Tears Figures
Table Key Players of Artificial Tears
Figure Punctal Plugs Figures
Table Key Players of Punctal Plugs
Figure Omega Supplements Figures
Table Key Players of Omega Supplements
Figure Others Figures
Table Key Players of Others
Table Global Xerophthalmia Treatment Market Size Growth by Application 2013-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Eye Health Clinics Case Studies
Figure Retail Pharmacies Case Studies
Figure Online Pharmacies Case Studies
Figure Xerophthalmia Treatment Report Years Considered
Table Global Xerophthalmia Treatment Market Size 2013-2025 (Million US$)
Figure Global Xerophthalmia Treatment Market Size and Growth Rate 2013-2025 (Million US$)
Table Global Xerophthalmia Treatment Market Size by Regions 2013-2025 (Million US$)
Table Global Xerophthalmia Treatment Market Size by Regions 2013-2018 (Million US$)
Table Global Xerophthalmia Treatment Market Share by Regions 2013-2018
Figure Global Xerophthalmia Treatment Market Share by Regions 2013-2018
Figure Global Xerophthalmia Treatment Market Share by Regions 2018
Table Market Top Trends
Table Global Xerophthalmia Treatment Revenue by Manufacturers (2013-2018) (Million US$)
Table Global Xerophthalmia Treatment Market Share by Manufacturers (2013-2018)
Figure Global Xerophthalmia Treatment Market Share by Manufacturers in 2018
Table Global Xerophthalmia Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Xerophthalmia Treatment Product/Solution/Service
Table Date of Enter into Xerophthalmia Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Xerophthalmia Treatment Market Size by Type (2013-2018) (Million US$)
Table Global Xerophthalmia Treatment Market Size Share by Type (2013-2018)
Figure Global Xerophthalmia Treatment Market Size Market Share by Type (2013-2018)
Table Global Xerophthalmia Treatment Market Size by Application (2013-2018) (Million US$)
Table Global Xerophthalmia Treatment Market Size Share by Application (2013-2018)
Figure Global Xerophthalmia Treatment Market Size Market Share by Application (2013-2018)
Figure Global Xerophthalmia Treatment Revenue Market Share by Application in 2017
Figure United States Xerophthalmia Treatment Market Size 2013-2018 (Million US$)
Table United States Key Players Xerophthalmia Treatment Revenue (2017-2018) (Million US$)
Table United States Key Players Xerophthalmia Treatment Market Share (2017-2018)
Table United States Xerophthalmia Treatment Market Size by Type (2013-2018) (Million US$)
Table United States Xerophthalmia Treatment Market Share by Type (2013-2018)
Table United States Xerophthalmia Treatment Market Size by Application (2013-2018) (Million US$)
Table United States Xerophthalmia Treatment Market Share by Application (2013-2018)
Figure Europe Xerophthalmia Treatment Market Size 2013-2018 (Million US$)
Table Europe Key Players Xerophthalmia Treatment Revenue (2017-2018) (Million US$)
Table Europe Key Players Xerophthalmia Treatment Market Share (2017-2018)
Table Europe Xerophthalmia Treatment Market Size by Type (2013-2018) (Million US$)
Table Europe Xerophthalmia Treatment Market Share by Type (2013-2018)
Table Europe Xerophthalmia Treatment Market Size by Application (2013-2018) (Million US$)
Table Europe Xerophthalmia Treatment Market Share by Application (2013-2018)
Figure China Xerophthalmia Treatment Market Size 2013-2018 (Million US$)
Table China Key Players Xerophthalmia Treatment Revenue (2017-2018) (Million US$)
Table China Key Players Xerophthalmia Treatment Market Share (2017-2018)
Table China Xerophthalmia Treatment Market Size by Type (2013-2018) (Million US$)
Table China Xerophthalmia Treatment Market Share by Type (2013-2018)
Table China Xerophthalmia Treatment Market Size by Application (2013-2018) (Million US$)
Table China Xerophthalmia Treatment Market Share by Application (2013-2018)
Figure Japan Xerophthalmia Treatment Market Size 2013-2018 (Million US$)
Table Japan Key Players Xerophthalmia Treatment Revenue (2017-2018) (Million US$)
Table Japan Key Players Xerophthalmia Treatment Market Share (2017-2018)
Table Japan Xerophthalmia Treatment Market Size by Type (2013-2018) (Million US$)
Table Japan Xerophthalmia Treatment Market Share by Type (2013-2018)
Table Japan Xerophthalmia Treatment Market Size by Application (2013-2018) (Million US$)
Table Japan Xerophthalmia Treatment Market Share by Application (2013-2018)
Figure Southeast Asia Xerophthalmia Treatment Market Size 2013-2018 (Million US$)
Table Southeast Asia Key Players Xerophthalmia Treatment Revenue (2017-2018) (Million US$)
Table Southeast Asia Key Players Xerophthalmia Treatment Market Share (2017-2018)
Table Southeast Asia Xerophthalmia Treatment Market Size by Type (2013-2018) (Million US$)
Table Southeast Asia Xerophthalmia Treatment Market Share by Type (2013-2018)
Table Southeast Asia Xerophthalmia Treatment Market Size by Application (2013-2018) (Million US$)
Table Southeast Asia Xerophthalmia Treatment Market Share by Application (2013-2018)
Figure India Xerophthalmia Treatment Market Size 2013-2018 (Million US$)
Table India Key Players Xerophthalmia Treatment Revenue (2017-2018) (Million US$)
Table India Key Players Xerophthalmia Treatment Market Share (2017-2018)
Table India Xerophthalmia Treatment Market Size by Type (2013-2018) (Million US$)
Table India Xerophthalmia Treatment Market Share by Type (2013-2018)
Table India Xerophthalmia Treatment Market Size by Application (2013-2018) (Million US$)
Table India Xerophthalmia Treatment Market Share by Application (2013-2018)
Figure Central & South America Xerophthalmia Treatment Market Size 2013-2018 (Million US$)
Table Central & South America Key Players Xerophthalmia Treatment Revenue (2017-2018) (Million US$)
Table Central & South America Key Players Xerophthalmia Treatment Market Share (2017-2018)
Table Central & South America Xerophthalmia Treatment Market Size by Type (2013-2018) (Million US$)
Table Central & South America Xerophthalmia Treatment Market Share by Type (2013-2018)
Table Central & South America Xerophthalmia Treatment Market Size by Application (2013-2018) (Million US$)
Table Central & South America Xerophthalmia Treatment Market Share by Application (2013-2018)
Table Allergan Plc Company Details
Table Allergan Plc Revenue in Xerophthalmia Treatment Business (2013-2018) (Million US$)
Figure Allergan Plc Revenue Growth Rate in Xerophthalmia Treatment Business (2013-2018)
Table Allergan Plc Recent Development
Table Novartis AG Company Details
Table Novartis AG Revenue in Xerophthalmia Treatment Business (2013-2018)(Million US$)
Figure Novartis AG Revenue Growth Rate in Xerophthalmia Treatment Business (2013-2018)
Table Novartis AG Recent Development
Table Otsuka Pharmaceutical Co.,Ltd. Company Details
Table Otsuka Pharmaceutical Co.,Ltd. Revenue in Xerophthalmia Treatment Business (2013-2018)(Million US$)
Figure Otsuka Pharmaceutical Co.,Ltd. Revenue Growth Rate in Xerophthalmia Treatment Business (2013-2018)
Table Otsuka Pharmaceutical Co.,Ltd. Recent Development
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in Xerophthalmia Treatment Business (2013-2018)(Million US$)
Figure Abbott Laboratories Revenue Growth Rate in Xerophthalmia Treatment Business (2013-2018)
Table Abbott Laboratories Recent Development
Table Santen Pharmaceutical Co Ltd Company Details
Table Santen Pharmaceutical Co Ltd Revenue in Xerophthalmia Treatment Business (2013-2018)(Million US$)
Figure Santen Pharmaceutical Co Ltd Revenue Growth Rate in Xerophthalmia Treatment Business (2013-2018)
Table Santen Pharmaceutical Co Ltd Recent Development
Table Valent Pharmaceuticals Company Details
Table Valent Pharmaceuticals Revenue in Xerophthalmia Treatment Business (2013-2018)(Million US$)
Figure Valent Pharmaceuticals Revenue Growth Rate in Xerophthalmia Treatment Business (2013-2018)
Table Valent Pharmaceuticals Recent Development
Table Akorn, Inc Company Details
Table Akorn, Inc Revenue in Xerophthalmia Treatment Business (2013-2018)(Million US$)
Figure Akorn, Inc Revenue Growth Rate in Xerophthalmia Treatment Business (2013-2018)
Table Akorn, Inc Recent Development
Table Shire Plc Company Details
Table Shire Plc Revenue in Xerophthalmia Treatment Business (2013-2018)(Million US$)
Figure Shire Plc Revenue Growth Rate in Xerophthalmia Treatment Business (2013-2018)
Table Shire Plc Recent Development
Table Thea Pharmaceuticals Limited Company Details
Table Thea Pharmaceuticals Limited Revenue in Xerophthalmia Treatment Business (2013-2018)(Million US$)
Figure Thea Pharmaceuticals Limited Revenue Growth Rate in Xerophthalmia Treatment Business (2013-2018)
Table Thea Pharmaceuticals Limited Recent Development
Table OASIS Medical Company Details
Table OASIS Medical Revenue in Xerophthalmia Treatment Business (2013-2018)(Million US$)
Figure OASIS Medical Revenue Growth Rate in Xerophthalmia Treatment Business (2013-2018)
Table OASIS Medical Recent Development
Table Altaire Pharmaceuticals Inc Company Details
Table Boiron USA Company Details
Table Similasan Corporation Company Details
Table Scope Ophthalmics Ltd. Company Details
Table Reckitt Benckiser Group PLC Company Details
Table Medicom Healthcare Ltd Company Details
Table FDC Limited Company Details
Table Lupin Limited Company Details
Table Jamjoom Pharmaceuticals Co. Company Details
Table Sentiss Pharma Private limited Company Details
Table Global Xerophthalmia Treatment Market Size by Regions (Million US$) 2018-2025
Figure Global Xerophthalmia Treatment Market Size Share by Regions (2018-2025)
Figure Global Xerophthalmia Treatment Market Size Share by Regions in 2025
Figure United States Xerophthalmia Treatment Market Size Forecast (2018-2025)(Million USD)
Figure Europe Xerophthalmia Treatment Market Size Forecast (2018-2025)(Million USD)
Figure China Xerophthalmia Treatment Market Size Forecast (2018-2025)(Million USD)
Figure Japan Xerophthalmia Treatment Market Size Forecast (2018-2025)(Million USD)
Figure Southeast Asia Xerophthalmia Treatment Market Size Forecast (2018-2025)(Million USD)
Figure India Xerophthalmia Treatment Market Size Forecast (2018-2025)(Million USD)
Figure Central & South America Xerophthalmia Treatment Market Size Forecast (2018-2025)(Million USD)
Table Global Xerophthalmia Treatment Market Size by Product (2018-2025) (Million US$)
Figure Global Xerophthalmia Treatment Market Size by Product (2018-2025)
Figure Global Xerophthalmia Treatment Market Size by Product in 2025
Table Global Xerophthalmia Treatment Market Size by Application (2018-2025) (Million US$)
Figure Global Xerophthalmia Treatment Market Size by Application (2018-2025)
Figure Global Xerophthalmia Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
